Introduction Infections caused by parasitic flatworms impose a considerable worldwide
health burden. Recently, World Health Organization launched its roadmap for neglected …

As an emerging novel drug carrier, nanoparticles provide a promising way for effective
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …

Schistosomiasis is one of the neglected tropical diseases that affect millions of people
worldwide. Globally, it affects economically poor countries, typically due to a lack of proper …

Background Schistosomiasis is a chronic debilitating parasitic disease accompanied with
severe mortality rates. Although praziquantel (PZQ) acts as the sole drug for the …

The brain is a vital organ that is protected from the general circulation and is distinguished
by the presence of a relatively impermeable blood brain barrier (BBB). Blood brain barrier …

Helminthiasis is one of the gravest problems worldwide. There is a growing concern on less
available anthelmintics and the emergence of resistance creating a major threat to human …

Schistosomiasis is one of the major parasitic diseases and second most prevalent among
the group of neglected diseases. The prevalence of schistosomiasis may be due to …

Despite the technological advancement in the era of personalized medicine and
therapeutics development, infectious parasitic causative agents remain one of the most …

Schistosomiasis, a neglected tropical parasitic disease, is associated with severe pathology,
mortality and economic loss. The treatment and control of schistosomiasis depends mainly …

Background The control of schistosomiasis has been centered to date on a single drug,
praziquantel, with shortcomings including treatment failure, reinfection, and emergence of …